A Case of Severe Chronic Heart Failure Successfully Controlled with Long Term Administration of Tolvaptan; a V(2)-specific Vasopressin Receptor Antagonists

被引：0
|
作者：
Yamagami, Yuna [1 ]
Kinoshita, Hideyuki [1 ]
Kuwahara, Koichiro [1 ]
Kuwabara, Yoshihiro [1 ]
Yasuno, Shinji [2 ]
Usami, Satoru [1 ]
Nakagawa, Yasuaki [1 ]
Nishikimi, Toshio [1 ]
Ueshima, Kenji [2 ]
Nakao, Kazuwa [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan
[2] Kyoto Univ, EBM Res Ctr, Kyoto, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2011年 / 17卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2011.06.565
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [1] Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
    Greenberg, Arthur
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (06) : 904 - 907
  • [2] Vasopressin receptor antagonists in patients with chronic heart failure
    De Vecchis, R.
    Cantatrione, C.
    Mazzei, D.
    HERZ, 2017, 42 (05) : 492 - 497
  • [3] Effects of the vasopressin V2 receptor antagonist, tolvaptan, on the long-term progression of left ventricular dilatation in patients with heart failure
    Udelson, JE
    Mcgrew, F
    Flores, E
    Ibrahim, H
    Koshkarian, G
    Katz, S
    O'Brien, T
    Zimmer, C
    Konstam, MA
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : 720 - 720
  • [4] Effects of the vasopressin V2 receptor antagonist, tolvaptan, on the long-term progression of left ventricular dilatation in patients with heart failure
    Udelson, JE
    McGrew, F
    Flores, E
    Ibrahim, H
    Koshkarian, G
    Katz, S
    O'Brien, T
    Johnson, RH
    Zimmer, C
    Orlandi, C
    Konstam, MA
    CIRCULATION, 2005, 112 (17) : U564 - U564
  • [5] The Efficacy of Long-Term Administration of Tolvaptan for Recurrent Heart Failure
    Kubota, Ryuji
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S204 - S205
  • [6] Three Cases of Tolvaptan, that is Vasopressin V2 Receptor Antagonisut, is Effective of Congestive Heart Failure
    Fujiwara, Syouhei
    Yuba, Masao
    Tateishi, Jun
    Masuyama, Tohru
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S166 - S166
  • [7] Clinical effect of long-term administration of tolvaptan in patients with heart failure and chronic kidney disease
    Ono, Yohei
    Takamatsu, Hiroto
    Inoue, Masahiro
    Mabuchi, Yukio
    Ueda, Tetsuya
    Suzuki, Tadashi
    Kurabayashi, Masahiko
    DRUG DISCOVERIES AND THERAPEUTICS, 2018, 12 (03): : 154 - 160
  • [8] Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan
    Nakao, Yasuhisa
    Kawakami, Hiroshi
    Saito, Makoto
    Inoue, Katsuji
    Ikeda, Shuntaro
    Yamaguchi, Osamu
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 408 - 416
  • [9] V2 receptor antagonism with tolvaptan in heart failure
    Costello-Boerrigter, Lisa C.
    Boerrigter, Guido
    Burnett, John C., Jr.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (10) : 1639 - 1647
  • [10] Long-term Effect of Tolvaptan in Patient with Chronic Heart Failure
    Shibahara, Toru
    Ikeda, Ken
    Fujiwara, Toshiya
    Nakagawa, Masayasu
    Kibira, Satoshi
    Ito, Hiroshi
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S150 - S150
12345